Spencer D. Dreher

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

1

Total Citations

647

H-Index

1

About

Spencer D. Dreher has pioneered the intersection of high-throughput experimentation and complex molecule synthesis, fundamentally reshaping how chemists approach reaction discovery and optimization. His landmark work on nanomole-scale automation—captured in a 2014 paper with over 647 citations—introduced a miniaturized platform that enables synthetic route scouting with vanishingly small quantities of material, a breakthrough that has become indispensable for drug discovery and natural product synthesis. By demonstrating that even the most intricate molecular transformations can be efficiently explored at sub-milligram scales, Dreher’s contributions have dramatically accelerated the pace of medicinal chemistry while reducing material waste. His research continues to bridge the gap between automated high-throughput methods and the nuanced demands of complex molecule construction, empowering researchers to rapidly identify optimal conditions for challenging reactions. Beyond this seminal work, Dreher’s influence is felt across the pharmaceutical industry, where his innovations have been widely adopted to streamline early-stage development. For students and researchers alike, his career exemplifies how creative engineering of experimental workflows can unlock new frontiers in synthetic chemistry.

Research Focus

Key Achievements

1
H-Index
1
Papers
647
Total Citations
647
Avg Citations/Paper
🏆 Most Cited Paper
Nanomole-scale high-throughput chemistry for the synthesis of complex molecules
647 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago